These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 27835864)

  • 1. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
    Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
    Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.
    Tesfai Y; Ford J; Carter KW; Firth MJ; O'Leary RA; Gottardo NG; Cole C; Kees UR
    Leuk Res; 2012 Mar; 36(3):299-306. PubMed ID: 21889797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy.
    Slone WL; Moses BS; Hare I; Evans R; Piktel D; Gibson LF
    Oncotarget; 2016 Apr; 7(17):23439-53. PubMed ID: 27015556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nelarabine-resistant T-lymphoblastic leukemia CCRF-CEM variant cell line is cross-resistant to the purine nucleoside phosphorylase inhibitor forodesine.
    Yamauchi T; Uzui K; Nishi R; Tasaki T; Ueda T
    Anticancer Res; 2014 Sep; 34(9):4885-92. PubMed ID: 25202070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia Maintenance.
    Pitt LA; Tikhonova AN; Hu H; Trimarchi T; King B; Gong Y; Sanchez-Martin M; Tsirigos A; Littman DR; Ferrando AA; Morrison SJ; Fooksman DR; Aifantis I; Schwab SR
    Cancer Cell; 2015 Jun; 27(6):755-68. PubMed ID: 26058075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 induces growth inhibition, apoptosis and differentiation in T and B cell-derived acute lymphoblastic leukemia cell lines (CCRF-CEM and Nalm-6).
    Soleymani Fard S; Jeddi Tehrani M; Ardekani AM
    Prostaglandins Leukot Essent Fatty Acids; 2012 Jul; 87(1):17-24. PubMed ID: 22749740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Glucocorticoid Resistance in Pediatric T-cell Acute Lymphoblastic Leukemia by Increasing BIM Expression with the PI3K/mTOR Inhibitor BEZ235.
    Hall CP; Reynolds CP; Kang MH
    Clin Cancer Res; 2016 Feb; 22(3):621-32. PubMed ID: 26080839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid childhood T-ALL growth in xenograft models correlates with mature phenotype and NF-κB pathway activation but not with poor prognosis.
    Poglio S; Cahu X; Uzan B; Besnard-Guérin C; Lapillonne H; Leblanc T; Baruchel A; Landman-Parker J; Petit A; Baleydier F; Amsellem S; Baud V; Ballerini P; Pflumio F
    Leukemia; 2015 Apr; 29(4):977-80. PubMed ID: 25371179
    [No Abstract]   [Full Text] [Related]  

  • 9. Stromal cell-mediated mitochondrial redox adaptation regulates drug resistance in childhood acute lymphoblastic leukemia.
    Liu J; Masurekar A; Johnson S; Chakraborty S; Griffiths J; Smith D; Alexander S; Dempsey C; Parker C; Harrison S; Li Y; Miller C; Di Y; Ghosh Z; Krishnan S; Saha V
    Oncotarget; 2015 Dec; 6(40):43048-64. PubMed ID: 26474278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma.
    De Smedt R; Morscio J; Reunes L; Roels J; Bardelli V; Lintermans B; Van Loocke W; Almeida A; Cheung LC; Kotecha RS; Mansour MR; Uyttebroeck A; Vandenberghe P; La Starza R; Mecucci C; Lammens T; Van Roy N; De Moerloose B; Barata JT; Taghon T; Goossens S; Van Vlierberghe P
    Blood; 2020 May; 135(19):1685-1695. PubMed ID: 32315407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell precursor acute lymphoblastic leukemia and stromal cells communicate through Galectin-3.
    Fei F; Joo EJ; Tarighat SS; Schiffer I; Paz H; Fabbri M; Abdel-Azim H; Groffen J; Heisterkamp N
    Oncotarget; 2015 May; 6(13):11378-94. PubMed ID: 25869099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance.
    Nowak D; Liem NL; Mossner M; Klaumünzer M; Papa RA; Nowak V; Jann JC; Akagi T; Kawamata N; Okamoto R; Thoennissen NH; Kato M; Sanada M; Hofmann WK; Ogawa S; Marshall GM; Lock RB; Koeffler HP
    Exp Hematol; 2015 Jan; 43(1):32-43.e1-35. PubMed ID: 25450514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice.
    Minuzzo S; Agnusdei V; Pusceddu I; Pinazza M; Moserle L; Masiero M; Rossi E; Crescenzi M; Hoey T; Ponzoni M; Amadori A; Indraccolo S
    Carcinogenesis; 2015 Jan; 36(1):115-21. PubMed ID: 25355291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterotypic paracrine signaling drives fibroblast senescence and tumor progression of large cell carcinoma of the lung.
    Lugo R; Gabasa M; Andriani F; Puig M; Facchinetti F; Ramírez J; Gómez-Caro A; Pastorino U; Fuster G; Almendros I; Gascón P; Davalos A; Reguart N; Roz L; Alcaraz J
    Oncotarget; 2016 Dec; 7(50):82324-82337. PubMed ID: 27384989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MLL-rearranged acute lymphoblastic leukaemia stem cell interactions with bone marrow stroma promote survival and therapeutic resistance that can be overcome with CXCR4 antagonism.
    Sison EA; Rau RE; McIntyre E; Li L; Small D; Brown P
    Br J Haematol; 2013 Mar; 160(6):785-97. PubMed ID: 23294096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells.
    Yan W; Wu X; Zhou W; Fong MY; Cao M; Liu J; Liu X; Chen CH; Fadare O; Pizzo DP; Wu J; Liu L; Liu X; Chin AR; Ren X; Chen Y; Locasale JW; Wang SE
    Nat Cell Biol; 2018 May; 20(5):597-609. PubMed ID: 29662176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia.
    Caracciolo D; Riillo C; Ballerini A; Gaipa G; Lhermitte L; Rossi M; Botta C; Duroyon E; Grillone K; Gallo Cantafio ME; Buracchi C; Alampi G; Gulino A; Belmonte B; Conforti F; Golino G; Juli G; Altomare E; Polerà N; Scionti F; Arbitrio M; Iannone M; Martino M; Correale P; Talarico G; Ghelli Luserna di Rorà A; Ferrari A; Concolino D; Sestito S; Pensabene L; Giordano A; Hildinger M; Di Martino MT; Martinelli G; Tripodo C; Asnafi V; Biondi A; Tagliaferri P; Tassone P
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33597219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia.
    Silveira AB; Laranjeira AB; Rodrigues GO; Leal PC; Cardoso BA; Barata JT; Yunes RA; Zanchin NI; Brandalise SR; Yunes JA
    Oncotarget; 2015 May; 6(15):13105-18. PubMed ID: 25869207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics of resistance to Notch1 inhibition in acute lymphoblastic leukemia reveals targetable kinase signatures.
    Franciosa G; Smits JGA; Minuzzo S; Martinez-Val A; Indraccolo S; Olsen JV
    Nat Commun; 2021 May; 12(1):2507. PubMed ID: 33947863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3,3'-Diindolylmethane induces G1 arrest and apoptosis in human acute T-cell lymphoblastic leukemia cells.
    Shorey LE; Hagman AM; Williams DE; Ho E; Dashwood RH; Benninghoff AD
    PLoS One; 2012; 7(4):e34975. PubMed ID: 22514694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.